Medical Experts Criticized the Involvement of Indonesian Inteligence Agency in Drug Trials

Last updated on May 18th, 2021 at 05:28 am

Medical experts have criticized Indonesia ‘s Intelligence Unit (BIN) and Army’s unwanted involvement in efforts to find a cure for Covid-19, claiming that the associated clinical trials violated international protocols.

This came after military chief Andika Perkasa announced that Indonesia was planning to produce drugs to fight coronavirus, and he expected BPOM, the U.S. Food and Drug Administration’s Indonesian equivalent, to authorize three existing drug combinations that he claimed could cure Covid-19.

BIN ‘s secretary, General Bambang Sunarwibowo, told MetroTV night that his agency began its efforts in March, because of concerns about the high rate of fatality and the rapid spread of the virus in Indonesia, and that BIN was funding this project.

In response to doctors who were perplexed by the involvement of an intelligence agency in a medical endeavor, according to General Bambang they initiated it. BIN is part of the government. Airlangga University, which works with BIN, the army and several hospitals, carried out the research.

The Airlangga University and BIN first announced in June that they had discovered five drug combinations to fight Covid-19. They also implemented three of these five variations in the following clinical trials. The three combinations are Azithromycin and Lopinavir / Ritonavir; Lopinavir / Ritonavir and Doxycycline; Hydrochloroquine and Azithromycin.

The University of Airlangga said in a presentation report about its clinical trial that the drugs under study showed their efficacy after three to seven days of administration, stressing that examination of kidney, liver and heart function later proved normal.

The trials were held from 7 July to 4 Aug. According to the 1report seen by The Straits Times, 754 of the 1,127 subjects who participated in the initial stage qualified after meeting the inclusion criteria. Researchers must specify criteria for participation in each clinical trial, factoring in the age , sex and past medical history of the participants.

Antara, the state news agency reported that Dr. Pandu Riono, who teaches at the medical school of the University of Indonesia, questioned the consortium ‘s failure to submit a report of its clinical trial to the World Health Organization International Clinical Trials Registry Platform, so that academics and researchers around the world could access it for transparency. The WHO’s registry platform serves to ensure a complete view of research is accessible to all those involved in healthcare decision making.

According to WHO This will improve research transparency and will ultimately strengthen the validity and value of the scientific evidence base

Platform registration includes documentation of a trial’s aims, architecture and procedures, as well as providing context and justification. Participants in the trials must be selected at random and represent different groups to reduce bias.

Prof Zubairi Djoerban, head of the coronavirus task force of the Indonesian Doctors Association, said on MetroTV that the University of Airlangga should have sought peer reviews on its study first before any public announcement.

The National Covid-19 task force issued a statement in an apparent move to prevent public confusion, citing Prof Ali Ghufron Mukti, head of the government’s Covid-19 research and innovation consortium, that said there is no specific drug that cures Covid-19 upto now.

Katherine S

1/4 German, 3/4 Malaysian. I write, follow and monitor closely political news happening in Malaysia, and other happening news in the ASEAN region. Newswriter for the best ASEAN news website - The Asian Affairs.

Recent Posts

China and UAE Celebrate 40 Years of Diplomatic Relations: All the Sectors for Partnership

Celebrating 40 years of diplomatic ties, China and the United Arab Emirates (UAE) are poised to fortify an alliance that…

November 2, 2024

What’s in Store for Squid Game Season 2: New Twists, International Adaptations, and a Bold Return to the Games

Fans of the worldwide sensation Squid Game have much to look forward to this December as the show's producer, Hwang…

November 2, 2024

TWICE Joins Coldplay’s ‘Music of the Spheres’ Tour for a Seoul Spectacle in 2025

Especially when it's the internationally known British rock band Coldplay linking up with K-pop phenomenon TWICE, few events match the…

November 2, 2024

China Caught in the Crossfire: Tensions Rise as North Korea and Russia Strengthen Alliance

Tucked on a 12-story structure in northeast China, visitors flock to get a rare view of the junction of their…

November 2, 2024

Could Westeros Dragons Soon Soar into the Big Screen? ‘Game of Thrones’ Film Reportedly in Early Development

HBO's Game of Thrones has created a void in the fantasy world of television that no other show has quite…

November 1, 2024

Preparing for U.S. Election Impact: Sen. Imee Marcos Urges Self-Reliant Defense Amid Uncertain Times

Head of the Senate Committee on Foreign Relations, Senator Imee Marcos underlined the need of the Philippines getting ready for…

November 1, 2024

This website uses cookies.

Read More